Quick Answer
BridgeBio Oncology Therapeutics, Inc. reported Shares Outstanding of 79.99 million shares for fiscal year 2025.
BridgeBio Oncology Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 79.99M | +281412.5% |
| 2024 | 28,415 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 79.20M | — | +278614.4% |
| December 31, 2024 | 28,415 | — | — |
- BridgeBio Oncology Therapeutics, Inc. showed an increase of +281412.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, BridgeBio Oncology Therapeutics, Inc.’s shares outstanding has grown by 281412.5% (from 28.4 thousand shares to 79.99 million shares).
- The most recent figure is from BridgeBio Oncology Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: